Andecaliximab, also known as GS-5745, represents a valuable investigative device within the field of immune analyses. This humanized monoclonal immunoglobulin selectively interacts with CD40 ligand (CD40L), a crucial compound involved in inflammatory responses. By blocking CD40L engagement with its